Nicotine Replacement Therapy Sampling for Smokers in the Community
NCT ID: NCT05881083
Last Updated: 2023-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1014 participants
INTERVENTIONAL
2023-06-17
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brief Behavioural Economic Intervention for Smoking Cessation
NCT06451081
Promoting Smoking Cessation in the Community Via QTW 2015
NCT02539875
Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2018
NCT03565796
Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2017
NCT03182790
Promoting Smoking Cessation in the Community Via Quit to Win Contest 2012
NCT01670864
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
1-week nicotine replacement therapy sample + Brief cessation advice
1-week nicotine replacement therapy sampling
Participants will be given an 1-week sample of nicotine replacement therapy (patch or gum) with brief instructions on how to use the product
Brief cessation advice
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model:
A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again
Control group
Brief cessation advice
Brief cessation advice
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model:
A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1-week nicotine replacement therapy sampling
Participants will be given an 1-week sample of nicotine replacement therapy (patch or gum) with brief instructions on how to use the product
Brief cessation advice
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model:
A: Ask about the tobacco use status; W: Warn about the hazards of tobacco use; A: Advise the smokers to quit; R: Refer the smokers to cessation services; D: Do-it-again
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Smoke cigarette or heated tobacco product or e-cigarette daily in the past 3 months
3. Exhaled carbon monoxide level ≥4 part per million or a positive salivary cotinine test
4. Able to communicate in and read Chinese
5. Have a local contact number
Exclusion Criteria
2. Pregnant or breastfeeding
3. Recent (≤ 2 weeks) angina, cardiac arrhythmia or heart attacks
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hong Kong Council on Smoking and Health
OTHER
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tzu Tsun Luk
Research Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tzu Tsun Luk, PhD, RN
Role: PRINCIPAL_INVESTIGATOR
The University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Community sites
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tzu Tsun Luk
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QTW2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.